PDB Short entry for 1V0P HEADER TRANSFERASE 01-APR-04 1V0P TITLE STRUCTURE OF P. FALCIPARUM PFPK5-PURVALANOL B LIGAND COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION CONTROL PROTEIN 2 HOMOLOG; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PFPK5; COMPND 5 EC: 2.7.1.22, 2.7.1.23; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 5833; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, KEYWDS 2 PHOSPHORYLATION, CDK EXPDTA X-RAY DIFFRACTION AUTHOR S.HOLTON,A.MERCKX,D.BURGESS,C.DOERIG,M.NOBLE,J.ENDICOTT REVDAT 4 31-MAR-10 1V0P 1 VERSN REVDAT 3 08-SEP-09 1V0P 1 COMPND REMARK DBREF SEQADV REVDAT 2 24-FEB-09 1V0P 1 VERSN REVDAT 1 06-MAY-04 1V0P 0 JRNL AUTH S.HOLTON,A.MERCKX,D.BURGESS,C.DOERIG,M.NOBLE, JRNL AUTH 2 J.ENDICOTT JRNL TITL STRUCTURES OF P. FALCIPARUM PFPK5 TEST THE CDK JRNL TITL 2 REGULATION PARADIGM AND SUGGEST MECHANISMS OF JRNL TITL 3 SMALL MOLECULE INHIBITION JRNL REF STRUCTURE V. 11 1329 2003 JRNL REFN ISSN 0969-2126 JRNL PMID 14604523 JRNL DOI 10.1016/J.STR.2003.09.020 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 105.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 36543 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1970 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1898 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE SET COUNT : 107 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4309 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 239 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.13000 REMARK 3 B22 (A**2) : 1.77000 REMARK 3 B33 (A**2) : 0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.197 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.933 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4465 ; 0.021 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6036 ; 1.820 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 529 ; 5.952 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 671 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3294 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2004 ; 0.231 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 265 ; 0.186 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.184 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.164 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2657 ; 1.358 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4292 ; 2.288 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1808 ; 2.853 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1744 ; 4.470 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 1V0P COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-APR-04. REMARK 100 THE PDBE ID CODE IS EBI-14919. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38513 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 27.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 111.32000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.18050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 111.32000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.18050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 HOH Z 46 LIES ON A SPECIAL POSITION. REMARK 375 HOH Z 47 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, VAL 161 TO ILE REMARK 400 ENGINEERED RESIDUE IN CHAIN B, VAL 161 TO ILE REMARK 400 REMARK 400 PLAYS A KEY ROLE IN THE CONTROL OF THE EUKARYOTIC CELL REMARK 400 CYCLE. IT IS REQUIRED IN HIGHER CELLS FOR ENTRY INTO REMARK 400 S-PHASE AND MITOSIS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 152 REMARK 465 PRO A 153 REMARK 465 VAL A 154 REMARK 465 ARG A 155 REMARK 465 LYS A 156 REMARK 465 TYR A 157 REMARK 465 THR A 158 REMARK 465 HIS A 159 REMARK 465 GLU A 160 REMARK 465 ASN A 287 REMARK 465 ASN A 288 REMARK 465 MET B 1 REMARK 465 LYS B 33 REMARK 465 ILE B 34 REMARK 465 ARG B 35 REMARK 465 LEU B 36 REMARK 465 GLU B 37 REMARK 465 LYS B 38 REMARK 465 GLU B 39 REMARK 465 ASP B 40 REMARK 465 GLU B 41 REMARK 465 GLY B 42 REMARK 465 ILE B 43 REMARK 465 LYS B 72 REMARK 465 LYS B 73 REMARK 465 ARG B 74 REMARK 465 GLY B 151 REMARK 465 ILE B 152 REMARK 465 PRO B 153 REMARK 465 VAL B 154 REMARK 465 ARG B 155 REMARK 465 LYS B 156 REMARK 465 TYR B 157 REMARK 465 THR B 158 REMARK 465 HIS B 159 REMARK 465 GLU B 160 REMARK 465 ILE B 161 REMARK 465 VAL B 162 REMARK 465 THR B 163 REMARK 465 ASN B 287 REMARK 465 ASN B 288 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 40 CB - CG - OD2 ANGL. DEV. = 6.8 DEGREES REMARK 500 ASP A 208 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 254 CB - CG - OD2 ANGL. DEV. = 7.3 DEGREES REMARK 500 ASP B 91 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 125 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP B 254 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 259 CB - CG - OD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP B 268 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 2 32.46 21.30 REMARK 500 LYS A 3 77.24 52.34 REMARK 500 LYS A 72 66.30 65.32 REMARK 500 HIS A 123 -65.66 -98.08 REMARK 500 ARG A 124 -3.17 77.76 REMARK 500 ASP A 125 36.74 -140.50 REMARK 500 ASP A 143 6.86 82.89 REMARK 500 TRP A 225 85.14 -152.22 REMARK 500 ASN A 227 -0.48 69.77 REMARK 500 LEU A 265 31.88 -95.83 REMARK 500 GLU B 8 117.42 -164.35 REMARK 500 ASN B 24 36.73 -84.18 REMARK 500 SER B 45 -24.81 -38.46 REMARK 500 GLU B 80 139.24 -37.34 REMARK 500 HIS B 123 -70.26 -93.86 REMARK 500 ARG B 124 -9.99 80.01 REMARK 500 ASN B 227 8.19 80.40 REMARK 500 LEU B 250 59.56 -142.13 REMARK 500 LEU B 265 41.08 -99.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PVB A1287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PVB B1287 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LCH RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF CELL DIVISION CONTROL REMARK 900 PROTEIN LIKEPROTEIN KINASE FROM HUMAN MALARIA REMARK 900 PARASITE PLASMODIUMFALCIPARUM REMARK 900 RELATED ID: 1OB3 RELATED DB: PDB REMARK 900 STRUCTURE OF P. FALCIPARUM PFPK5 REMARK 900 RELATED ID: 1V0B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE T198A MUTANT OF PFPK5 REMARK 900 RELATED ID: 1V0O RELATED DB: PDB REMARK 900 STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5 REMARK 900 -SULPHONATE LIGAND COMPLEX DBREF 1V0P A 1 288 UNP Q07785 CDC2H_PLAFK 1 288 DBREF 1V0P B 1 288 UNP Q07785 CDC2H_PLAFK 1 288 SEQADV 1V0P ILE A 161 UNP Q07785 VAL 161 ENGINEERED MUTATION SEQADV 1V0P ILE B 161 UNP Q07785 VAL 161 ENGINEERED MUTATION SEQRES 1 A 288 MET GLU LYS TYR HIS GLY LEU GLU LYS ILE GLY GLU GLY SEQRES 2 A 288 THR TYR GLY VAL VAL TYR LYS ALA GLN ASN ASN TYR GLY SEQRES 3 A 288 GLU THR PHE ALA LEU LYS LYS ILE ARG LEU GLU LYS GLU SEQRES 4 A 288 ASP GLU GLY ILE PRO SER THR THR ILE ARG GLU ILE SER SEQRES 5 A 288 ILE LEU LYS GLU LEU LYS HIS SER ASN ILE VAL LYS LEU SEQRES 6 A 288 TYR ASP VAL ILE HIS THR LYS LYS ARG LEU VAL LEU VAL SEQRES 7 A 288 PHE GLU HIS LEU ASP GLN ASP LEU LYS LYS LEU LEU ASP SEQRES 8 A 288 VAL CYS GLU GLY GLY LEU GLU SER VAL THR ALA LYS SER SEQRES 9 A 288 PHE LEU LEU GLN LEU LEU ASN GLY ILE ALA TYR CYS HIS SEQRES 10 A 288 ASP ARG ARG VAL LEU HIS ARG ASP LEU LYS PRO GLN ASN SEQRES 11 A 288 LEU LEU ILE ASN ARG GLU GLY GLU LEU LYS ILE ALA ASP SEQRES 12 A 288 PHE GLY LEU ALA ARG ALA PHE GLY ILE PRO VAL ARG LYS SEQRES 13 A 288 TYR THR HIS GLU ILE VAL THR LEU TRP TYR ARG ALA PRO SEQRES 14 A 288 ASP VAL LEU MET GLY SER LYS LYS TYR SER THR THR ILE SEQRES 15 A 288 ASP ILE TRP SER VAL GLY CYS ILE PHE ALA GLU MET VAL SEQRES 16 A 288 ASN GLY THR PRO LEU PHE PRO GLY VAL SER GLU ALA ASP SEQRES 17 A 288 GLN LEU MET ARG ILE PHE ARG ILE LEU GLY THR PRO ASN SEQRES 18 A 288 SER LYS ASN TRP PRO ASN VAL THR GLU LEU PRO LYS TYR SEQRES 19 A 288 ASP PRO ASN PHE THR VAL TYR GLU PRO LEU PRO TRP GLU SEQRES 20 A 288 SER PHE LEU LYS GLY LEU ASP GLU SER GLY ILE ASP LEU SEQRES 21 A 288 LEU SER LYS MET LEU LYS LEU ASP PRO ASN GLN ARG ILE SEQRES 22 A 288 THR ALA LYS GLN ALA LEU GLU HIS ALA TYR PHE LYS GLU SEQRES 23 A 288 ASN ASN SEQRES 1 B 288 MET GLU LYS TYR HIS GLY LEU GLU LYS ILE GLY GLU GLY SEQRES 2 B 288 THR TYR GLY VAL VAL TYR LYS ALA GLN ASN ASN TYR GLY SEQRES 3 B 288 GLU THR PHE ALA LEU LYS LYS ILE ARG LEU GLU LYS GLU SEQRES 4 B 288 ASP GLU GLY ILE PRO SER THR THR ILE ARG GLU ILE SER SEQRES 5 B 288 ILE LEU LYS GLU LEU LYS HIS SER ASN ILE VAL LYS LEU SEQRES 6 B 288 TYR ASP VAL ILE HIS THR LYS LYS ARG LEU VAL LEU VAL SEQRES 7 B 288 PHE GLU HIS LEU ASP GLN ASP LEU LYS LYS LEU LEU ASP SEQRES 8 B 288 VAL CYS GLU GLY GLY LEU GLU SER VAL THR ALA LYS SER SEQRES 9 B 288 PHE LEU LEU GLN LEU LEU ASN GLY ILE ALA TYR CYS HIS SEQRES 10 B 288 ASP ARG ARG VAL LEU HIS ARG ASP LEU LYS PRO GLN ASN SEQRES 11 B 288 LEU LEU ILE ASN ARG GLU GLY GLU LEU LYS ILE ALA ASP SEQRES 12 B 288 PHE GLY LEU ALA ARG ALA PHE GLY ILE PRO VAL ARG LYS SEQRES 13 B 288 TYR THR HIS GLU ILE VAL THR LEU TRP TYR ARG ALA PRO SEQRES 14 B 288 ASP VAL LEU MET GLY SER LYS LYS TYR SER THR THR ILE SEQRES 15 B 288 ASP ILE TRP SER VAL GLY CYS ILE PHE ALA GLU MET VAL SEQRES 16 B 288 ASN GLY THR PRO LEU PHE PRO GLY VAL SER GLU ALA ASP SEQRES 17 B 288 GLN LEU MET ARG ILE PHE ARG ILE LEU GLY THR PRO ASN SEQRES 18 B 288 SER LYS ASN TRP PRO ASN VAL THR GLU LEU PRO LYS TYR SEQRES 19 B 288 ASP PRO ASN PHE THR VAL TYR GLU PRO LEU PRO TRP GLU SEQRES 20 B 288 SER PHE LEU LYS GLY LEU ASP GLU SER GLY ILE ASP LEU SEQRES 21 B 288 LEU SER LYS MET LEU LYS LEU ASP PRO ASN GLN ARG ILE SEQRES 22 B 288 THR ALA LYS GLN ALA LEU GLU HIS ALA TYR PHE LYS GLU SEQRES 23 B 288 ASN ASN HET PVB A1287 30 HET PVB B1287 30 HETNAM PVB PURVALANOL B HETSYN PVB 2-CHLORO-4-{[2-{[(1R)-1-(HYDROXYMETHYL)-2- HETSYN 2 PVB METHYLPROPYL]AMINO}-9-(1-METHYLETHYL)-9H-PURIN- HETSYN 3 PVB 6-YL]AMINO}BENZOIC ACID FORMUL 3 PVB 2(C20 H25 CL N6 O3) FORMUL 4 HOH *239(H2 O) HELIX 1 1 PRO A 44 ILE A 53 1 10 HELIX 2 2 LEU A 54 LEU A 57 5 4 HELIX 3 3 LEU A 86 VAL A 92 1 7 HELIX 4 4 GLU A 98 ARG A 119 1 22 HELIX 5 5 LYS A 127 GLN A 129 5 3 HELIX 6 6 GLY A 145 GLY A 151 1 7 HELIX 7 7 ALA A 168 MET A 173 1 6 HELIX 8 8 THR A 180 GLY A 197 1 18 HELIX 9 9 SER A 205 GLY A 218 1 14 HELIX 10 10 ASN A 227 LEU A 231 5 5 HELIX 11 11 PRO A 245 PHE A 249 5 5 HELIX 12 12 ASP A 254 LEU A 265 1 12 HELIX 13 13 ASP A 268 ARG A 272 5 5 HELIX 14 14 THR A 274 GLU A 280 1 7 HELIX 15 15 HIS A 281 LYS A 285 5 5 HELIX 16 16 PRO B 44 LEU B 54 1 11 HELIX 17 17 LYS B 55 LEU B 57 5 3 HELIX 18 18 LEU B 86 CYS B 93 1 8 HELIX 19 19 GLU B 98 ARG B 119 1 22 HELIX 20 20 LYS B 127 GLN B 129 5 3 HELIX 21 21 GLY B 145 PHE B 150 1 6 HELIX 22 22 ALA B 168 MET B 173 1 6 HELIX 23 23 THR B 180 GLY B 197 1 18 HELIX 24 24 SER B 205 GLY B 218 1 14 HELIX 25 25 ASN B 227 LEU B 231 5 5 HELIX 26 26 PRO B 245 LEU B 250 1 6 HELIX 27 27 ASP B 254 LEU B 265 1 12 HELIX 28 28 ASP B 268 ARG B 272 5 5 HELIX 29 29 THR B 274 GLU B 280 1 7 HELIX 30 30 HIS B 281 LYS B 285 5 5 SHEET 1 AA 5 TYR A 4 GLY A 13 0 SHEET 2 AA 5 GLY A 16 ASN A 23 -1 O GLY A 16 N GLY A 13 SHEET 3 AA 5 THR A 28 ILE A 34 -1 O PHE A 29 N ALA A 21 SHEET 4 AA 5 LEU A 75 GLU A 80 -1 O LEU A 75 N ILE A 34 SHEET 5 AA 5 LEU A 65 HIS A 70 -1 N TYR A 66 O VAL A 78 SHEET 1 AB 3 GLN A 84 ASP A 85 0 SHEET 2 AB 3 LEU A 131 ILE A 133 -1 O ILE A 133 N GLN A 84 SHEET 3 AB 3 LEU A 139 ILE A 141 -1 O LYS A 140 N LEU A 132 SHEET 1 BA 5 HIS B 5 GLY B 13 0 SHEET 2 BA 5 GLY B 16 GLN B 22 -1 O GLY B 16 N GLY B 13 SHEET 3 BA 5 THR B 28 LYS B 32 -1 O PHE B 29 N ALA B 21 SHEET 4 BA 5 VAL B 76 PHE B 79 -1 O LEU B 77 N LYS B 32 SHEET 5 BA 5 LEU B 65 ILE B 69 -1 N TYR B 66 O VAL B 78 SHEET 1 BB 3 GLN B 84 ASP B 85 0 SHEET 2 BB 3 LEU B 131 ILE B 133 -1 O ILE B 133 N GLN B 84 SHEET 3 BB 3 LEU B 139 ILE B 141 -1 O LYS B 140 N LEU B 132 SITE 1 AC1 14 ILE A 10 GLY A 11 GLU A 12 GLY A 13 SITE 2 AC1 14 ALA A 30 GLU A 80 LEU A 82 ASP A 83 SITE 3 AC1 14 ASP A 85 GLN A 129 LEU A 132 ALA A 142 SITE 4 AC1 14 HOH A2144 HOH A2145 SITE 1 AC2 14 ILE B 10 GLY B 11 GLU B 12 GLY B 13 SITE 2 AC2 14 ALA B 30 PHE B 79 GLU B 80 HIS B 81 SITE 3 AC2 14 LEU B 82 ASP B 83 ASP B 85 GLN B 129 SITE 4 AC2 14 LEU B 132 ALA B 142 CRYST1 222.640 44.361 63.762 90.00 103.19 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004491 0.000000 0.001053 0.00000 SCALE2 0.000000 0.022542 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016108 0.00000